ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO167

Thioredoxin-Interacting Protein (TXNIP) Regulates Mitochondrial Function and Prognosis of Ischemia/Reperfusion Induced AKI

Session Information

  • Mitochondriacs and More
    November 03, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Acute Kidney Injury

  • 001 AKI: Basic


  • Inogtani, Satoshi, Kochi university, Nankokushi, Japan
  • Hashimoto, Daisuke, Kochi university, Nankokushi, Japan
  • Ogasawara, Masami, Kochi university, Nankokushi, Japan
  • Eguchi, Tomohiro, Kochi university, Nankokushi, Japan
  • Nishikawa, Hirofumi, Kochi university, Nankokushi, Japan
  • Matsumoto, Tatsuki, Kochi university, Nankokushi, Japan
  • Ode, Kazu Hamada, Kochi university, Nankokushi, Japan
  • Shimamura, Yoshiko, Kochi Medical School,Kochi University, Nankoku, Japan
  • Inoue, Kosuke, kochi medical school, Nankoku, Japan
  • Taniguchi, Yoshinori, Kochi university, Nankokushi, Japan
  • Horino, Taro, Kochi Medical School, Kochi University, Kochi, Japan
  • Terada, Yoshio, None, Nankoku-city, Japan

Thioredoxin-interacting protein (TXNIP) has been found to regulate the cellular reduction-oxidation (redox) state by binding to and inhibiting thioredoxin in a redox-dependent fashion. However, little is known about the role of TXNIP in mitochondrial function and acute kidney injury (AKI) pathogenesis.


We evaluated the role of TXNIP in renal function in bilateral renal ischemia (27 min)/reperfusion injury (IRI) model using TXNIP knock-out (KO) and wild type (WT) mice. To elucidate the functional roles of TXNIP, we evaluated mitochondrial enzymes, morphology, and NLRP3 inflammasome in primary cultured renal tubular epithelial cells (TECs).


TXNIP KO mice had significantly higher SCr (0.78+0.28 versus 0.45 + 0.20 mg/dl) and significantly higher BUN (152.5+32.5 versus 75.3+18.2 mg/dl) at 24h post ischemia compared to WT mice. Immunohistological examination showed severer tubular injury in cortex and outer medulla in TXNIP KO mice. The number of TUNEL positive tubular cells and KIM-1 positive cells were increased in in TXNIP KO mice. Dysmorphic mitochondria were observed in proximal tubules of TXNIP KO mice compared to WT mice. The protein expressions of mitochondrial enzymes (ATP5a, UCP2 and complex IV) and ATP production were decreased in TXNIP KO mice at 24h post ischemia. In vitro experiments, protein and mRNA levels of ATP5a, complex IV, PGC-1a were significantly decreased by H2O2, and these reductions were more prominent in TECs of TXNIP KO mice. Moreover, NLRP3, IL-1β, and caspase 1 (p10) protein expressions were significantly increased by LPS in TECs of WT mice, but this effect was reduced in TECs of TXNIP KO mice.


These data demonstrate that TXNIP protects from IRI induced AKI. TXNIP regulates mitochondrial function and inflammasome in cytotoxic conditions. These results indicate that TXNIP plays a key role in the pathophysiology of AKI.